Hemlibra (Emicizumab) 30 mg/mL Injection
Hemlibra 30 mg/mL Injection is a prescription biologic medicine used for the prevention of bleeding episodes in patients with hemophilia A. It contains Emicizumab, a humanized monoclonal antibody that replaces the function of missing clotting factor VIII and helps the blood clot more effectively. It is used as a long-term preventive therapy to reduce spontaneous and repeated bleeding episodes in hemophilia A patients, including those with inhibitors.
Contact Details to Place Order
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
Composition and Content
- Active Ingredient: Emicizumab
- Strength: 30 mg/mL
- Dosage Form: Subcutaneous injection (solution)
- Drug Class: Bispecific monoclonal antibody / Hemostatic biologic
How It Works
Hemlibra works by:
- Mimicking the function of clotting factor VIII
- Bridging activated factor IX and factor X
- Restoring the blood clotting process in hemophilia A
- Preventing spontaneous and recurrent bleeding episodes
This provides continuous protection rather than treating bleeding after it occurs.
Uses and Treatments
Hemlibra (Emicizumab) Injection is used for:
- Hemophilia A (congenital factor VIII deficiency)
- Hemophilia A with factor VIII inhibitors
- Hemophilia A without inhibitors
- Prevention of recurrent bleeding episodes
- Long-term prophylactic (preventive) therapy
Dosage and How to Use
- Administered as a subcutaneous injection
- Given weekly, every 2 weeks, or monthly depending on prescription
- Initial loading dose followed by maintenance dosing
- Should be administered by healthcare professionals or trained caregivers
Important: Dosage is strictly individualized and must be followed by a hematologist.
Advantages of Hemlibra
- Reduces frequency of bleeding episodes
- Effective in patients with or without inhibitors
- Long-lasting preventive protection
- Less frequent dosing compared to factor replacement therapy
- Improves quality of life in hemophilia patients
Storage Conditions
- Store in refrigerator (2°C to 8°C)
- Do not freeze
- Keep in original carton to protect from light
- Do not shake vigorously
- Keep out of reach of children
Alternative Indian Brands / Options
Currently, Emicizumab is a patented biologic, so direct Indian generic versions are not available. However, hemophilia management alternatives in India include:
- Factor VIII concentrates by Shire (Takeda Pharmaceuticals)
- Plasma-derived clotting factors by Reliance Life Sciences
- Recombinant clotting factor products by Bharat Serums and Vaccines
Note: Any change in therapy must be done under hematologist supervision.
Buy Hemlibra Emicizumab 30 mg/mL Injection Online in South Africa – Trusted Biologic Medicine Exporter
Looking to buy Hemlibra Emicizumab 30 mg/mL Injection in South Africa? GlobMedIndia is a trusted international medicine exporter of biologic and hematology treatments, offering safe, genuine, and high-quality medicines with secure global delivery across South Africa and surrounding regions including Botswana, Lesotho, Mozambique, Namibia, Eswatini, and Zimbabwe.
We ensure delivery across major cities such as:
Johannesburg, Cape Town, Pretoria, Polokwane, Germiston, and Nelspruit.
Why Choose GlobMedIndia?
- Trusted exporter of biologic medicines worldwide
- Cold-chain secure international shipping
- Fast and discreet delivery service
- 100% genuine and quality-assured products
- Reliable global healthcare supplier
- Buy Hemlibra Injection South Africa
- Emicizumab 30 mg/mL price Johannesburg
- Hemophilia A treatment Africa
- Hemlibra supplier South Africa online
- Anti bleeding injection Africa delivery
- Biologic medicine exporter South Africa
- GlobMedIndia hematology medicines
👉 Order Now for Fast, Safe & Secure Delivery Across South Africa & Neighboring Countries!
